Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

The substance shows substantial first-pass metabolism by the liver after oral exposure, and is rapidly eliminated from the blood, primarily in the urine, after intravenous dosing.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential
Absorption rate - oral (%):
20
Absorption rate - dermal (%):
1

Additional information

The pharmacokinetics of 2-ethyl-1,3-hexanediol, administered intravenously, were examined in rats at high and low doses. Values for pharmacokinetic parameters were obtained which indicate metabolism by the liver (80%) and rapid elimination from the blood, primarily in the urine. Absorption through the skin of rats is slow. A comparative study between the absorptive parameters of human, rat and rabbit skin was undertaken in vitro with undiluted EHD and a 3% aqueous solution of EHD. Female rabbit skin absorbed undiluted EHD most effectively, followed by rat and lastly, human. Human skin absorbed less than 1% of the administered concentration of undiluted EHD. Absorption of undiluted EHD was approximately 3-fold higher in rats than in human skin. Absorption of dilute EHD (3% aqueous solution in water) was comparable between rat and human, but half the amount absorbed by rabbit skin.